تقرير
Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report.
العنوان: | Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report. |
---|---|
المؤلفون: | Shantzer LB; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Dougherty SC; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Bolte F; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Melson JW; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Reed DR; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Lynch AC; Department of Pharmacy, University of Virginia Health System, Charlottesville, VA., Gentzler RD; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA., Novicoff W; Department of Public Health Sciences and Orthopaedic Surgery, HSC, University of Virginia Health System, Charlottesville, VA., Hall RD; Department of Medicine, Division of Hematology-Oncology, University of Virginia Health System, Charlottesville, VA. Electronic address: rdh3q@uvahealth.org. |
المصدر: | Clinical lung cancer [Clin Lung Cancer] 2023 Mar; Vol. 24 (2), pp. e60-e64. Date of Electronic Publication: 2022 Nov 26. |
نوع المنشور: | Case Reports; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2011-: [New York] : Elsevier Original Publication: Dallas, Tex. : Cancer Information Group, c1999- |
مواضيع طبية MeSH: | Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/therapy, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Immunotherapy/adverse effects |
فهرسة مساهمة: | Keywords: Immunotherapy; Multimodality therapy; Multisystem; Toxicity; Treatment |
المشرفين على المادة: | 0 (Immune Checkpoint Inhibitors) 0 (Antibodies, Monoclonal) |
تواريخ الأحداث: | Date Created: 20221216 Date Completed: 20230223 Latest Revision: 20230321 |
رمز التحديث: | 20240628 |
DOI: | 10.1016/j.cllc.2022.11.006 |
PMID: | 36526550 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1938-0690 |
---|---|
DOI: | 10.1016/j.cllc.2022.11.006 |